Can Vasopharm Be First To EU Market With Novel TBI Drug?
Executive Summary
Small German firm, Vasopharm, wants to be the first company to bring a therapeutic treatment to the European market for use in patients with traumatic brain injuries – but getting the drug through Phase III studies alone will be its biggest test yet.